CS Cancer Solutions - Structured Oncology Intelligence

Cancer Research Platform Pricing | Patient Memberships & Institutional Plans

Educational Research Access

For Individuals and Institutions

Annual professional license • No medical data required

Clinician Access Levels

From basic visibility to full research intelligence

Annual professional license

Individual Professional License
$999annually

For: General physicians, NPs, PAs, early-career oncologists

Includes:

  • Advanced cancer type summaries (clinician version)
  • Drug approvals: FDA/EMA/NMPA/PMDA
  • Clinical trial search (professional interface)
  • Diagnostic pathway overviews
  • Specialist directory access
  • Global treatment guidelines overview
  • Weekly oncology updates digest

Best suited for:

Affordable for individual clinicians with attractive upsell path

Advanced Clinical Research License
$2,999annually

For: Practicing oncologists, hem/onc specialists, radiation oncologists

Includes:

  • Everything in Basic +
  • Biomarker → treatment intelligence
  • Precision oncology updates
  • Molecular diagnostics summaries
  • Full drug pipeline intelligence
  • Country-by-country treatment comparison
  • Priority alerts on new clinical trials
  • Access to professional global oncology database

Best suited for:

Hugely valuable at far below typical $500–$1,500/yr evidence intelligence tools

Clinical Leadership License
$7,500annually

For: Senior oncologists, tumor board members, cancer researchers

Includes:

  • Everything in Pro, plus:
  • Full Research section access
  • Academic publication insights
  • Early-phase trial tracking
  • Annual Oncology Research Compendium (PDF)
  • Advanced evidence synthesis tools
  • CME-ready research modules
  • Secure case review workspace (non-PHI)
  • Clinical trial routing support

Best suited for:

Complete research and evidence support for senior oncologists

Stay Informed With Global Cancer Research

Get important oncology updates, clinical trial openings, and research breakthroughs delivered to your inbox.

We respect your privacy. No medical information required.

Why Choose Cancer Solutions

Trusted Evidence

Research synthesized from globally recognized oncology institutions and peer-reviewed sources, following standardized governance and review processes

Global Reach

Access to specialists and clinical trials worldwide

Secure & Private

HIPAA compliant with bank-level encryption

Frequently Asked Questions

Are the patient plans really free?

Can I upgrade or downgrade my patient plan?

What's included in Institutional plans?

How does the Clinical Trial Lead program work?

Can I purchase add-ons without an institutional plan?

Do you offer custom enterprise solutions?

Is my health information secure?

International Access

All membership levels include:

Worldwide cancer center directory
Global clinical trial listings
Research updates from China, Japan, Europe, Australia, Canada, and the U.S.
International innovation summaries
Nobel-winning research breakthroughs

🏥 Institutional Access Levels

Advanced oncology intelligence for hospitals, cancer centers, and research networks.

CS Cancer Solutions delivers a governance-aligned, non-PHI oncology intelligence platform designed to support institutional research visibility, portfolio balance, and translational strategy across oncology domains.

Institutional Evidence Suite

For mid-tier cancer programs seeking structured research visibility.

Supports organization-wide oncology evidence awareness and portfolio-level insight.

Access includes:

  • Organization-wide oncology intelligence
  • Unlimited institutional users
  • Structured evidence summaries
  • Monthly oncology intelligence briefings
  • Quarterly research strategy sessions
  • Licensing for internal education and reference

Engagement structured according to institutional size and scope. Pilot and phased deployment options available.

Precision Oncology Enterprise Package

For expanding systems and multi-site oncology programs.

Supports cross-site research coordination and precision oncology program visibility.

Includes all Institutional Evidence Suite capabilities, plus:

  • Multi-site institutional licensing
  • Advanced oncology intelligence layers
  • Custom institutional support
  • Priority evidence updates
  • Annual educational programs

Engagement defined collaboratively based on organizational scale.

Enterprise Oncology Intelligence Infrastructure

For regional systems, NCI-designated centers, and multi-hospital networks operating at scale.

Supports enterprise-wide oncology intelligence infrastructure and executive-level oncology strategy alignment.

Access includes:

  • Enterprise-scale licensing
  • System-wide oncology evidence access
  • Dedicated institutional support
  • Custom intelligence modules
  • Executive-level strategy briefings
  • Advanced deployment options

Architecture and deployment defined during executive engagement.

🔷 CS Cancer Solutions is structured to scale from single-site research visibility to enterprise-wide oncology intelligence infrastructure — without reliance on protected health information or clinical system integration.

Institutions typically begin with a focused deployment and expand over time as value is demonstrated.

Privacy & Platform Scope
No personal medical information required
No health records or PHI collected
CS Cancer Solutions is an independent oncology intelligence platform designed to support understanding — not direct care.

Ready To Get Started?

Individual access • Institutional solutions • No contracts

✓ Free to Premium options • HIPAA compliant • Enterprise-ready

Huippu Prodigy Platforms

© 2025 Huippu Prodigy Platforms, Inc.

CS Cancer Solutions, Inc. (Operating Company)

Evidence-Governed • Informed by Current Peer-Reviewed Research

Independent, Unbiased Oncology Intelligence